Clinical Laserthermia Systems AB (publ)

OM:CLS B Stock Report

Market Cap: SEK 83.6m

Clinical Laserthermia Systems Future Growth

Future criteria checks 2/6

Clinical Laserthermia Systems is forecast to grow earnings and revenue by 58.2% and 58.7% per annum respectively.

Key information

58.2%

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth32.8%
Revenue growth rate58.7%
Future return on equityn/a
Analyst coverage

Low

Last updated26 Aug 2024

Recent future growth updates

No updates

Recent updates

We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Jan 03
We Think Clinical Laserthermia Systems (STO:CLS B) Needs To Drive Business Growth Carefully

Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Aug 26
Will Clinical Laserthermia Systems (STO:CLS B) Spend Its Cash Wisely?

Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Mar 01
Clinical Laserthermia Systems (STO:CLS B) Is Making Moderate Use Of Debt

Earnings and Revenue Growth Forecasts

OM:CLS B - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202679N/AN/AN/A1
12/31/202554-27-24-221
12/31/202429-46-51-521
9/30/202418-64-65-59N/A
6/30/202415-68-63-59N/A
3/31/202411-71-75-72N/A
12/31/20238-80-72-66N/A
9/30/20238-63-74-70N/A
6/30/20237-77-81-78N/A
3/31/20236-78-85-82N/A
12/31/20226-71-82-82N/A
9/30/20223-81-81-81N/A
6/30/20222-63-66-66N/A
3/31/20222-68-71-71N/A
12/31/20212-64-67-66N/A
9/30/20211-60-63-63N/A
6/30/20212-57-55-55N/A
3/31/20212-47-41-41N/A
12/31/20201-58-56-55N/A
9/30/20201-58-54-53N/A
6/30/20202-57-54-54N/A
3/31/20206-54-52-52N/A
12/31/20196-43-39-39N/A
9/30/20196-38-37-36N/A
6/30/20195-37-35-34N/A
3/31/20191-41-44-43N/A
12/31/20188-33-41-39N/A
9/30/201810-28-33-31N/A
6/30/201811-24N/A-31N/A
3/31/201812-15N/A-24N/A
12/31/20178-21N/A-24N/A
9/30/20178-22N/A-29N/A
6/30/20178-26N/A-24N/A
3/31/20176-27N/A-23N/A
12/31/20164-27N/A-20N/A
9/30/20161-27N/A-19N/A
6/30/20160-23N/A-22N/A
3/31/20160-20N/A-17N/A
12/31/2015N/A-17N/A-19N/A
9/30/20150-21N/A-21N/A
6/30/20150-20N/A-20N/A
3/31/20150-20N/A-19N/A
12/31/2014N/A-18N/A-16N/A
9/30/20140-16N/A-18N/A
6/30/2014N/A-16N/A-18N/A
3/31/2014N/A-17N/A-17N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CLS B is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CLS B is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CLS B is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CLS B's revenue (58.7% per year) is forecast to grow faster than the Swedish market (1.2% per year).

High Growth Revenue: CLS B's revenue (58.7% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CLS B's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y